The agreement expands on an existing partnership and grants Psyence the right to commercialize Filament's natural psilocybin drug candidate PEX010 25mg within palliative care
Read more at newswire.caFILAMENT HEALTH AND PSYENCE ANNOUNCE WORLDWIDE LICENSING AGREEMENT OF PSILOCYBIN CAPSULE FOR PALLIATIVE CARE
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here